The Woodlands, TX, United States of America

Jeff Liu

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Lexicon Pharmaceuticals, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeff Liu. Retrieved from https://idiyas.com/inventor/jeff-liu-axpwn2i7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeff Liu: Innovator in Biomedicine

Introduction

Jeff Liu is a prominent inventor based in The Woodlands, Texas. He has made significant contributions to the field of biomedicine, particularly through his innovative work on antibodies.

Latest Patents

Jeff Liu holds a patent for "Antibodies that bind Notum Pectinacetylesterase." This patent describes antibodies that neutralize Notum Pectinacetylesterase, along with compositions that include these antibodies. The methods outlined in the patent aim to treat diseases and disorders affecting the bone. He has 1 patent to his name.

Career Highlights

Liu is currently employed at Lexicon Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for various medical conditions.

Collaborations

Throughout his career, Jeff Liu has collaborated with notable colleagues, including David George Potter and Robert Joseph Brommage, Jr. These partnerships have enhanced his research and contributed to the success of his projects.

Conclusion

Jeff Liu's innovative work in the field of biomedicine, particularly with his patent on antibodies, showcases his commitment to advancing medical science. His contributions are vital for developing new treatments for bone-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…